I take very strong exception to your characterization of my post as "pumping". I always call it like I see it - nothing we say here will impact the stock price up or down, so there is no point burning integrity on either pumping or bashing. Consequently, I am inclined to take very strong exception to your suggestion that I was pumping.
From MY perspective, the jury is still out on the cancer program. While not a DVAX sponsored trial, the study being run by Stanford and BMY is ongoing - not cancelled. If you knew anything about Dr. Levy, you would not be so pessimistic about the clinical results.
But maybe you don't care about clinical results - and, to be fair, whether DVAX shareholders will make any money if SD-101 is effective in this trial is a different question than whether the clinical results will be good.